Skip to content

Clinical trials

Multiple Myeloma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: Belgium Clear all

149 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20032
20041
20053
20063
20084
20093
20107
20117
20125
20134
20146
20157
20169
201711
20183
20199
202010
202111
202214
20237
20248
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Active, not recruiting26
Recruiting24
Terminated14
Unknown status7
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC23
Celgene18
Amgen7
European Organisation for Research and Treatment of Cancer - EORTC6
Sanofi6
Bristol-Myers Squibb5
Pfizer5
AbbVie4
Intergroupe Francophone du Myelome4
Millennium Pharmaceuticals, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma149
Recurrence23
Lymphoma, Non-Hodgkin12
Neoplasms, Plasma Cell12
Leukemia, Myeloid, Acute11
Neoplasms10
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Leukemia, Lymphocytic, Chronic, B-Cell9
Hodgkin Disease8
Lymphoma8

Trials

Showing 76 to 100 of 149. Each trial links to its page on Pharma Observatory.

49 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.